Delphinus Medical Technologies, LLC develops, commercializes, sells, and services the breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presence of benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. The company was founded in 2009 and is based in Detroit, Michigan.
Delphinus Medical Technologies total Funding
Delphinus Medical Technologies latest funding size
Time since last funding
|3 years ago|
Delphinus Medical Technologies investors
|Arboretum Ventures, North Coast Technology Investors, Waycross Ventures, Beringea, Venture Investors, Hopen Life Science Ventures|